Visual Acuity

In a study, the Tecnis Eyhance toric II IOL had good rotational stability over 3 months, significant reduction of cylinder, significant improvement of distance vision and some gain at intermediate.

In this Healio Video Perspective, Jay S. Duker, MD, chief operating officer of EyePoint Pharmaceuticals, discusses EYP-1901 for the treatment of wet age-related macular degeneration.

Cataract surgery improved visual acuity for patients with intermediate age-related macular degeneration and neovascular AMD, according to a study published in the Canadian Journal of Ophthalmology.

BOSTON – Innovega Inc.’s iOptik smart contact lens showed positive results in a phase 2 clinical trial involving subjects wearing the contacts with and without the company’s display eye wear.

Patients with Leber hereditary optic neuropathy treated with Lumevoq experienced sustained efficacy and safety after 2 years as part of the phase 3 REFLECT clinical trial, according to a press release from GenSight Biologics.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Dan Reinstein, MD, discusses the results of a study investigating SMILE in nearly 4,000 eyes.

Three topical ophthalmic formulations designed to treat presbyopia demonstrated positive results in the phase 2 VIVID clinical trial, Visus Therapeutics announced in a press release.

NEW ORLEANS — Patients with malignant glaucoma, or aqueous misdirection, who received surgical management were more likely to have better visual outcomes, according to a speaker at the American Academy of Ophthalmology meeting.

NEW ORLEANS — Patients with intermediate dry age-related macular degeneration experienced meaningful improvement in visual acuity after treatment with risuteganib, according to a study.

NEW ORLEANS — Initial results from the ALTITUDE study suggest that suprachoroidal RGX-314 is well tolerated in the treatment of diabetic retinopathy, according to a speaker here.